Vitamin Blue Stock Performance
| VTMB Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vitamin Blue are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vitamin Blue has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Vitamin Blue is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -7017.00 |
Vitamin |
Vitamin Blue Relative Risk vs. Return Landscape
If you would invest 0.01 in Vitamin Blue on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Vitamin Blue or generate 0.0% return on investment over 90 days. Vitamin Blue is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Vitamin, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vitamin Blue Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vitamin Blue's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Vitamin Blue, and traders can use it to determine the average amount a Vitamin Blue's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VTMB |
Based on monthly moving average Vitamin Blue is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vitamin Blue by adding Vitamin Blue to a well-diversified portfolio.
Vitamin Blue Fundamentals Growth
Vitamin Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vitamin Blue, and Vitamin Blue fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vitamin Pink Sheet performance.
| Return On Asset | -1.4 | |||
| Operating Margin | (0.78) % | |||
| Current Valuation | 766.89 K | |||
| Shares Outstanding | 783.4 M | |||
| Price To Earning | (0.40) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 250.03 K | |||
| EBITDA | (112.37 K) | |||
| Cash And Equivalents | 2.52 K | |||
| Total Debt | 307.37 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 7.69 K | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 31.72 K | |||
| Retained Earnings | (2.84 M) | |||
| Current Asset | 30 K | |||
| Current Liabilities | 736 K | |||
About Vitamin Blue Performance
By analyzing Vitamin Blue's fundamental ratios, stakeholders can gain valuable insights into Vitamin Blue's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vitamin Blue has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vitamin Blue has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Vitamin Blue performance evaluation
Checking the ongoing alerts about Vitamin Blue for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vitamin Blue help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vitamin Blue generated a negative expected return over the last 90 days | |
| Vitamin Blue has some characteristics of a very speculative penny stock | |
| Vitamin Blue has a very high chance of going through financial distress in the upcoming years | |
| Vitamin Blue currently holds 307.37 K in liabilities. Vitamin Blue has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vitamin Blue until it has trouble settling it off, either with new capital or with free cash flow. So, Vitamin Blue's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vitamin Blue sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vitamin to invest in growth at high rates of return. When we think about Vitamin Blue's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 250.03 K. Net Loss for the year was (21.08 K) with profit before overhead, payroll, taxes, and interest of 55.5 K. |
- Analyzing Vitamin Blue's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vitamin Blue's stock is overvalued or undervalued compared to its peers.
- Examining Vitamin Blue's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vitamin Blue's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vitamin Blue's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vitamin Blue's pink sheet. These opinions can provide insight into Vitamin Blue's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |